ocriplasmin

Known as: Microplasmin 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
PURPOSE To evaluate the efficacy of a single intravitreal injection of ocriplasmin 125 μg across relevant subpopulations of… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
2015
2015
BACKGROUND To evaluate the anatomical outcome of patients after vitrectomy due to persisting symptomatic vitreomacular traction… (More)
  • figure 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2014
Highly Cited
2014
OBJECTIVE To evaluate the anatomical and visual outcomes of patients treated with ocriplasmin for the treatment of symptomatic… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2014
2014
Our ability to examine the vitreoretinal interface has been greatly improved by the invention of spectral-domain optical… (More)
Is this relevant?
2013
2013
Ocriplasmin is a recombinant protease recently approved for the treatment of symptomatic vitreomacular adhesion (VMA). According… (More)
  • figure 1
Is this relevant?
2012
2012
The vitreous may play an important role in the pathogenesis of various retinal disorders. Pharmacologic vitreolysis uses… (More)
Is this relevant?
Review
2012
Review
2012
Fibronectin and laminin are clinically relevant plasmin receptors in the eye. Located at the vitreoretinal interface, they are… (More)
Is this relevant?
2012
2012
PURPOSE Ocriplasmin contains the active moiety of plasmin enzyme. At a physiologic pH, ocriplasmin is highly proteolytic and… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2002
2002
BACKGROUND AND PURPOSE It has been proposed that the novel thrombolytic microplasmin may be useful in the treatment of ischemic… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?